CRI Worldwide Opens Center for the Research of Pain Disorders in Philadelphia
Posted on: Thursday, 8 May 2008, 12:00 CDT
CRI Worldwide, Inc., a leading provider of clinical research services to the global pharmaceutical and biotech industry, has announced the opening of its Center for the Research of Pain Disorders, based at the company's state-of-the-art clinical research facility at the Kirkbride Center in Philadelphia. The Center for the Research of Pain Disorders will be led by Daniel Gruener, MD, a recognized expert in the areas of analgesic and neuropathic pain research.
"The opening of our Center for the Research of Pain Disorders is a very exciting milestone for CRI as we continue our growth in the Central Nervous System space," remarked Ken King, President and CEO. "The recent expansion of the Kirkbride Center provides the ideal setting to allow Dr. Gruener and his highly knowledgeable clinical staff to deepen CRI's commitment to understanding chronic and acute pain, pain management, and to supporting the emerging technologies in these areas."
CRI's Center for the Research of Pain Disorders will conduct Phase I through Phase IV inpatient and outpatient clinical trial services, with specific expertise in bioequivalence, bioavailability, PK/PD studies, cardiac safety (QTc), and proof of concept work. The Center's staff has conducted more than 100 clinical trials, including extensive experience in neuropathic pain, post hepatic neuralgia back pain and fibromyalgia.
Daniel Gruener, MD is Board Certified in Pain Medicine and Psychiatry, with more than 20 years of experience researching analgesics, pain management models, and emerging technologies aimed at resolving chronic pain. Dr. Gruener has extensive experience as a teacher, practitioner and writer in the fields of acute and chronic pain, as well as pain management and psychiatry.
Dr. Gruener currently serves as President of the Greater Philadelphia Pain Society, the Mid-Atlantic branch of the American Pain Society, and has edited the Society's publication, Pain Control in the Hospital. He recently coauthored the textbook Cognitive Therapy with Chronic Pain Patients with Dr. Aaron Beck of the University of Pennsylvania. Dr. Gruener completed his training at Jefferson Medical College in Philadelphia.
About CRI Worldwide
CRI Worldwide, Inc., with headquarters in Clementon, NJ, is a leading provider of Phase I-IV clinical development testing and research services for central nervous system (CNS), psychiatric, pain and other drug compounds. The company conducts inpatient and outpatient studies in fully licensed and accredited acute care hospitals. Additional information is available at www.criww.com.
Source: Business Wire
Related Articles
- U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold
- American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards
- Winnick Family Clinical Research Center Celebrates 6th Anniversary
- Capital Orthopaedic &Amp; Sports Medicine Center Deploys SRSsoft Clinical Manager(TM) in a Record 44 Business Days
- Children Can Be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord Blood Transplantation: Results From ViaCell and Children's Hospital & Research Center Oakland
- Clinical Data Launches Pain Research Services
- Hadasit Announces Hadassah Hospital's New Clinical Research Center
- Baxter Initiates Multi-Center Phase II Clinical Trial to Manage Fluid Overload in Congestive Heart Failure Patients
- Wyeth Sets Up Its Globally First Clinical Research Center
- Alere Medical Acquires Disease Management Business of National Jewish Medical and Research Center
 |
 |
User Comments (0)
RSS Feeds